Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease (Q24202744)

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Effects of adding salmeterol/fluticasone propionate to tiotropium on airway dimensions in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Comparison of tiotropium plus fluticasone propionate/salmeterol with tiotropium in COPD: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Cost effectiveness of budesonide/formoterol added to tiotropium bromide versus placebo added to tiotropium bromide in patients with chronic obstructive pulmonary disease: Australian, Canadian and Swedish healthcare perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Tiotropium bromide step-up therapy for adults with uncontrolled asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Tiotropium for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Self-management education for patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

The effect of adding inhaled corticosteroids to tiotropium and long-acting beta(2)-agonists for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Long-acting beta(2)-agonist in addition to tiotropium versus either tiotropium or long-acting beta(2)-agonist alone for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Tiotropium versus placebo for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Pulmonary rehabilitation for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Inhaled corticosteroids versus long-acting beta2-agonists for chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Methodological issues in therapeutic trials of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Methodologic shortcomings of the INSPIRE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Inhaled corticosteroids for stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Triple therapy for chronic obstructive pulmonary disease: trials catching up with clinical practice?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Premature discontinuation of patients: a potential bias in COPD clinical trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007891.PUB3

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/14651858.CD007891.PUB3

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4596646

OpenCitations bibliographic resource ID

4596646

1 reference